Thimerosal
CAS No. 54-64-8
Thimerosal( Thiomersalate | Mercurothiolate )
Catalog No. M19490 CAS No. 54-64-8
Thimerosal is an organomercurial compound and derivative of thiosalicyclic acid with antibacterial and antifungal properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameThimerosal
-
NoteResearch use only, not for human use.
-
Brief DescriptionThimerosal is an organomercurial compound and derivative of thiosalicyclic acid with antibacterial and antifungal properties.
-
DescriptionThimerosal is an organomercurial compound and derivative of thiosalicyclic acid with antibacterial and antifungal properties. Although the mechanism of action has not been fully elucidated thimerosal inhibits sulfhydryl-containing active site of various enzymes and binds to sulfhydryl compounds such as glutathione cysteine and SH groups of proteins. In addition thimerosal activates the InsP3 calcium channel on endoplasmic reticular membrane thereby triggering the release of calcium from intracellular stores resulting in a calcium-induced calcium-influx of extracellular calcium. Consequently thimerosal may induce or inhibit cellular functions dependent on calcium signaling.
-
In Vitro——
-
In VivoThe Thimerosal (THIM) administration increases μ-opioid receptors (MORs) density in the periaqueductal gray (PAG) in a dose-dependent manner. Treatment with higher doses of Thimerosal statistically significantly increases MOR density in the dorsomedial periaqueductal gray (DMPAG) andlateral periaqueductal gray (LPAG) regions. At the dose 3,000 μg Hg/kg, Thimerosal also augments MOR density in the caudate putamen (CPU). In contrast, the administration of Thimerosal at both higher doses decreases MOR density in the dentate gyrus (DG). Thimerosal administration (4 injections, i.m., 240 μg Hg/kg on postnatal days 7, 9, 11, 15) induces lasting changes in amino acid overflow: an increase of glutamate and aspartate accompanied by a decrease of glycine and alanine; measured 10 to 14 weeks after the injections. Four injections of Thimerosal at a dose of 12.5 μg Hg/kg do not alter glutamate and aspartate concentrations at microdialysis time. Application of Thimerosal to the prefrontal cortex (PFC) in perfusion fluid evokes a rapid increase of glutamate overflow. Coadministration of the neurosteroid, dehydroepiandrosterone sulfate (DHEAS; 80 mg/kg; i.p.) prevents the Thimerosal effect on glutamate and aspartate; the steroid alone has no influence on these amino acids. Coapplication of dehydroepiandrosterone sulfate (DHEAS) with Thimerosal in perfusion fluid also blocks the acute action of Thimerosal on glutamate.
-
SynonymsThiomersalate | Mercurothiolate
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInflammation/Immunology
-
IndicationSeptic; Fungal Infection
Chemical Information
-
CAS Number54-64-8
-
Formula Weight404.81
-
Molecular FormulaC9H9HgNaO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li X et al. Toxicol Sci. 2014 Jun;139(2):452-65.
molnova catalog
related products
-
Imipenem monohydrate
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria.
-
Hexyl gallate
Hexyl gallate, an alkyl ester derivative of gallic acid, exhibits potent antimalarial activity against Plasmodium falciparum (IC50: 0.11 mM).
-
QcrB inhibitor TB47
QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.